FDA Adds Targets To Semi-Annual Regulatory Agenda, Pushes Some Back
This article was originally published in The Tan Sheet
You may also be interested in...
Guidance Underscores FDA Practice Of Letting TEAs Steep
The viability of time and extent applications as a route to market for new OTC ingredients continues to wane in light of new final guidance on the process.
Guidance Underscores FDA Practice Of Letting TEAs Steep
The viability of time and extent applications as a route to market for new OTC ingredients continues to wane in light of new final guidance on the process.
Guidance Underscores FDA Practice Of Letting TEAs Steep
The viability of time and extent applications as a route to market for new OTC ingredients continues to wane in light of new final guidance on the process.